These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 10421454)

  • 21. Serum paraoxonase and cholinesterase activities in individuals with lipid and glucose metabolism disorders.
    Pavković E; Simeon V; Reiner E; Sućić M; Lipovac V
    Chem Biol Interact; 1993 Jun; 87(1-3):179-82. PubMed ID: 8393741
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Differentiation of esterases reacting with organophosphorus compounds.
    Reiner E; Pavković E; Radić Z; Simeon V
    Chem Biol Interact; 1993 Jun; 87(1-3):77-83. PubMed ID: 8393750
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Studies on serum esterases in cancer. Cholinesterase and arylesterase activity].
    Vincent D; Sesqué G; Marquès-Vincent MC
    Ann Biol Clin (Paris); 1967; 25(3):461-7. PubMed ID: 6050424
    [No Abstract]   [Full Text] [Related]  

  • 24. Interaction between human serum esterases and environmental metal compounds.
    Hernández AF; Gil F; Leno E; López O; Rodrigo L; Pla A
    Neurotoxicology; 2009 Jul; 30(4):628-35. PubMed ID: 19393262
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Serum paraoxonase activity and phenotype distribution in Turkish subjects with coronary heart disease and its relationship to serum lipids and lipoproteins.
    Karakaya A; Ibiş S; Kural T; Köse SK; Karakaya AE
    Chem Biol Interact; 1999 Apr; 118(3):193-200. PubMed ID: 10362226
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Serum paraoxonase and arylesterase activities in hemodialysis patients.
    Itahara T; Suehiro T; Ikeda Y; Inoue M; Nakamura T; Kumon Y; Kawada M; Hashimoto K
    J Atheroscler Thromb; 2000; 7(3):152-8. PubMed ID: 11480456
    [TBL] [Abstract][Full Text] [Related]  

  • 27. An improved method for phenotyping individuals for the human serum paraoxonase arylesterase polymorphism.
    La Du BN; Piko JI; Eckerson HW; Vincent-Viry M; Siest G
    Ann Biol Clin (Paris); 1986; 44(4):369-72. PubMed ID: 3024532
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of exposure to organophosphate pesticides on serum cholinesterase levels.
    López-Carillo L; López-Cervantes M
    Arch Environ Health; 1993; 48(5):359-63. PubMed ID: 8215602
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Paraoxonase activities in Minnan and Hakka.
    Lin TJ; Jiang DD; Hung DZ; Yang DY; Hsu CL; Tsai MS
    Kaohsiung J Med Sci; 2002 Nov; 18(11):551-6. PubMed ID: 12513017
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Low serum paraoxonase: a risk factor for atherosclerotic disease?
    Mackness MI; Durrington PN; Ayub A; Mackness B
    Chem Biol Interact; 1999 May; 119-120():389-97. PubMed ID: 10421475
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of the molecular polymorphisms of human paraoxonase (PON1) on the rate of hydrolysis of paraoxon.
    Mackness B; Mackness MI; Arrol S; Turkie W; Durrington PN
    Br J Pharmacol; 1997 Sep; 122(2):265-8. PubMed ID: 9313934
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sources of exposure to and public health implications of organophosphate pesticides.
    Jaga K; Dharmani C
    Rev Panam Salud Publica; 2003 Sep; 14(3):171-85. PubMed ID: 14653904
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Paraoxonase protects against chlorpyrifos toxicity in mice.
    Li WF; Furlong CE; Costa LG
    Toxicol Lett; 1995 Apr; 76(3):219-26. PubMed ID: 7539166
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of organophosphate intoxication on human serum paraoxonase.
    Sözmen EY; Mackness B; Sözmen B; Durrington P; Girgin FK; Aslan L; Mackness M
    Hum Exp Toxicol; 2002 May; 21(5):247-52. PubMed ID: 12141395
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Serum paraoxonase (PON1) 55 and 192 polymorphism and paraoxonase activity and concentration in non-insulin dependent diabetes mellitus.
    Mackness B; Mackness MI; Arrol S; Turkie W; Julier K; Abuasha B; Miller JE; Boulton AJ; Durrington PN
    Atherosclerosis; 1998 Aug; 139(2):341-9. PubMed ID: 9712341
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Modulation of the endogenous antioxidants paraoxonase-1 and urate by pesticide exposure and genetic variants of xenobiotic-metabolizing enzymes.
    Hernández AF; Gil F; Lacasaña M; Rodríguez-Barranco M; Gómez-Martin A; Lozano D; Pla A
    Food Chem Toxicol; 2013 Nov; 61():164-70. PubMed ID: 23747713
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The role of PON1 and CYP2D6 genes in susceptibility to organophosphorus chronic intoxication in Egyptian patients.
    Tawfik Khattab AM; Zayed AA; Ahmed AI; AbdelAal AG; Mekdad AA
    Neurotoxicology; 2016 Mar; 53():102-107. PubMed ID: 26723569
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of insulin resistance on serum paraoxonase activity in a nondiabetic population.
    Yamada A; Shoji T; Tahara H; Emoto M; Nishizawa Y
    Metabolism; 2001 Jul; 50(7):805-11. PubMed ID: 11436186
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Paraoxonase 1 phenotype and paraoxonase activity in asthmatic patients.
    Sarioglu N; Hismiogullari AA; Erel F; Demir D; Gencer N
    Iran J Allergy Asthma Immunol; 2015 Feb; 14(1):60-6. PubMed ID: 25530140
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Serum paraoxonase activity is decreased in uremic patients.
    Schiavon R; De Fanti E; Giavarina D; Biasioli S; Cavalcanti G; Guidi G
    Clin Chim Acta; 1996 Mar; 247(1-2):71-80. PubMed ID: 8920228
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.